Indeed, similarly to what is noted for T2DM [16], even moderate weight loss (e.g., 5–10%) in women with PCOS has been shown to have clinically important benefits to insulin resistance, menstrual regularity, the severity of hyperandrogenaemia and QoL [17,18,19]. The gene discussed is INS; the disease is polycystic ovary syndrome.